APLM
APLM
NASDAQ · Biotechnology

Apollomics Inc

$17.32
-1.28 (-6.88%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target -28.5% upside
Low Target $7.78
Average Target $12.39
High Target $16.73
Current Price $17.32
Current
$17.32
Target
$12.39
$7.78 $12.39 avg $16.73
Scenario Analysis
Bear Case
$7.78
-55.1%
Low target
Base Case
$12.39
-28.5%
Avg target
Bull Case
$16.73
+-3.4%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$28.29
-38.8% from high
52-Week Low
$11.30
+53.3% from low
Target vs 52W High
$12.39
-56.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%